RE:M&AGood point, but "M&A activity" is a 2 way street the first you are merging start source or the acquisition start source. The other side of the street, you merge with someone bigger or are acquired by someone bigger. Why do you think Virtu ITG is working retail shareholders with multiple accounts, to make 1/2 a cent per share? They are shaking the retail tree as hard as possible to see how many less informed shareholders they can shake out of their shares. It's all about making as much money as possible and that is what their activity should be telling you.
The key to a lot of this is which company licensed EPM patents to produce or have produced for them the acid form of cannabinoids. Is it LABS or their global pharma partner? I have a tendency to lean towards the global pharma partner holding those licenses and LABS, as a certified cannabinoid pharma facility produces the product. That makes sense to me and why a global pharma is partnered with LABS while 'for competitive reasons' holds things in secrecy.
Bourla, CEO of Pfizer, interestingly enough attended the Xi-Biden event because Pfizer does have a deal with China to improve health care for China and interestingly enough China is doing advanced cannabinoid research on advanced derivatives including the acid forms. That I could easily say, has a Pfizer touch IF Pfizer has the patents on acid stabilization form.
I could also say that China is doing that development work because they've kicked with economic sanctions and restrictions by the regime that thinks they run everything on this Planet. A rude awakening is unfolding right before your very eyes, a cliche, history in the making, just like the collapse of the Roman empire that wanted to rule everything as well. History does repeat itself and so too not a recession but the real risk of a depression in North America.